LRRC15 myofibroblasts dictate the stromal setpoint to suppress tumour immunity
Nature - LRRC15-positive cancer-associated fibroblasts constitute a pivotal axis in tumorigenesis and are potential therapeutic targets to improve responses to immune checkpoint blockade.
nature.com